医学
冲程(发动机)
治疗窗口
重症监护医学
放射性武器
急性中风
临床试验
抵押品
外科
内科学
组织纤溶酶原激活剂
机械工程
工程类
药理学
财务
经济
作者
Pierre Seners,Jean‐Claude Baron,Anke Wouters,Jean‐Philippe Désilles,Fernando Pico,Richard Macrez,Jean‐Marc Olivot,Robin Lemmens,Gregory W. Albers,Maarten G. Lansberg
出处
期刊:Stroke
[Lippincott Williams & Wilkins]
日期:2024-11-06
标识
DOI:10.1161/strokeaha.124.049167
摘要
Currently, most acute ischemic stroke patients presenting with a large vessel occlusion are first evaluated at a nonthrombectomy-capable center before transfer to a comprehensive stroke center that performs thrombectomy. Interfacility transfer is a complex process that requires extensive coordination between the referring, transporting, and receiving facilities. As a result, long delays are common, contributing to poor clinical outcomes. In this review, we summarize the accumulating literature about the clinical as well as radiological—infarct growth, collateral change, arterial recanalization, and hemorrhagic transformation—changes during interfacility transfer for thrombectomy. Recent evidence shows that clinical/radiological changes during transfer are heterogeneous across patients and impact long-term functional outcomes, highlighting the urgent need to optimize care during this time window. We review some of the most promising therapeutic strategies—for example, penumbral protection to reduce infarct growth—that may improve clinical outcome in patients being transferred to thrombectomy-capable centers. Finally, we discuss key methodological considerations for designing clinical trials aimed at reducing infarct growth during transfer.
科研通智能强力驱动
Strongly Powered by AbleSci AI